All In Biotech

Free tool

Drug Search

Every brand-name drug and biologic application (NDA or BLA) in Drugs@FDA: 5,899 in all. Generic (ANDA) applications are not listed; their reference drug is.

Last checked: Nov 20, 2026Drugs@FDA last updated: Nov 18, 2026Methods & limitations

14 matches for "Avyxa Holdings"

Brand names that start with your search come first, then marketed and novel drugs.

DrugSponsorApplicationFirst approvedPrograms
Axtle

Pemetrexed Dipotassium

Avyxa HoldingsNDA210661Jun 28, 2024
Axycis

Cisplatin

Avyxa HoldingsNDA220748Oct 29, 2026
Avopef

Etoposide

Avyxa HoldingsNDA220200Feb 13, 2026
Kyxata

Carboplatin

Avyxa HoldingsNDA219921Aug 8, 2025
Oxderys

Doxorubicin Hydrochloride

Avyxa HoldingsNDA221093Nov 9, 2026
Favlyxa

Fluorouracil

Avyxa HoldingsNDA220201Feb 20, 2026
Vykoura

Leucovorin Calcium

Avyxa HoldingsNDA220406Feb 3, 2026
Avgemsi

Gemcitabine Hydrochloride

Avyxa HoldingsNDA219920Jun 27, 2025
Posfrea

Palonosetron Hydrochloride

Avyxa HoldingsNDA203050Mar 1, 2016
Gobarden

Bendamustine Hydrochloride

Avyxa HoldingsNDA219014Jul 3, 2025
Navitrux

Fosaprepitant Dimeglumine

Avyxa HoldingsNDA220436Jun 24, 2026
Cligavyx

Fulvestrant

Avyxa HoldingsNDA210063Aug 19, 2019
Frindovyx

Cyclophosphamide

Avyxa HoldingsNDA210852Jun 7, 2023
Docetaxel

Docetaxel

Avyxa HoldingsNDA215813Nov 22, 2022

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.